US FDA Collects ‘Majority’ Of PDUFA Program Fees After Payment Plea
Executive Summary
The revenue is expected to sustain the prescription drug user fee program moving forward after reserves were tapped at the start of fiscal year 2023.
You may also be interested in...
New GDUFA Workload Formula Will Not Include Inspections Until FY 2025 Fee-Setting
Capacity planning adjustment that will help calculate generic drug user fees will not include inspections at first to allow more time for time reporting system implementation.
New GDUFA Workload Formula Will Not Include Inspections Until FY 2025 Fee-Setting
Capacity planning adjustment that will help calculate generic drug user fees will not include inspections at first to allow more time for time reporting system implementation.
FDA Reforms Missed By FDORA Could Find Vehicle In Animal Drug User Fee, Pandemic Bills
The usually lower-profile user fee reauthorizations could gain more attention for broader US FDA issues, said Andi Lipstein Fristedt, FDA deputy commissioner for policy, legislation and international affairs.